Bank Of New York Mellon Corp Ab Cellera Biologics Inc. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.31 - $11.18 $5.76 Million - $8.81 Million	787,979 New	787,979 $5.94 Billion
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $7.54 Million - $11.5 Million	795,085 New	795,085 $8.05 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $751,695 - $1.12 Million	81,706 Added 11.85%	771,244 $7.63 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $3.94 Million - $7.34 Million	689,538 New	689,538 $7.34 Million
Q4 2021 Feb 11, 2022	SELL	$12.99 - $17.73 $371,682 - $507,308	-28,613 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$14.85 - $21.34 $896,316 - $1.29 Million	-60,358 Reduced 67.84%	28,613 $573,000
Q2 2021 Aug 11, 2021	BUY	$20.19 - $34.17 $1.8 Million - $3.04 Million	88,971 New	88,971 $1.96 Million

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.